Residual Variants May Predict Relapse, Death in AML
Residual variants are associated with a higher risk of relapse and death among AML patients undergoing HSCT in first remission, a study suggests.
Residual variants are associated with a higher risk of relapse and death among AML patients undergoing HSCT in first remission, a study suggests.
Iomab-B plus RIC enables ASCT in a population of AML patients who are not typically eligible for transplant, a phase 3 study suggests.
Living along the Texas-Mexico border is associated with worse survival in children diagnosed with acute lymphoblastic leukemia.
Patients with abnormal chest CTs had worse overall survival, nonrelapse mortality, and pulmonary-related death after allo-HSCT.
Reinfusion with the CAR T-cell therapy tisagenlecleucel does not produce durable remissions in children and AYAs with B-ALL, a study suggests.
Maternal infections, especially genital and urinary tract infections, during pregnancy are associated with an increased risk of childhood leukemia in offspring, a study suggests.
From 2020 to 2050, the global economic cost of cancers is projected to be $25.2 trillion in international dollars.
Survivors of pediatric cancer have a higher rate of clonal hematopoiesis than their peers at any age, a study suggests.
Medication errors may be common in children with leukemia or lymphoma, and these errors can lead to serious harm, a new study suggests.
Comorbidity burden is an independent predictor of survival in older patients with acute promyelocytic leukemia.